Log in

Start Your Membership Now

March 14, 2011 Medical marijuana, legal in 15 states and the District of Columbia, should be federally regulated according to the American Society of Addiction Medicine (ASAM) to strengthen and standardize patient safeguards normally associated with the appropriate clinical use of psychoactive substances. The state-level policies for medical marijuana create a “patchwork system” of safeguards, leaving physicians to regulate use of a substance not approved by the U.S. Food and Drug Administration as medicine. Reliable dosing does not exist, production is not standardized, nor has marijuana been thoroughly tested in the same way as other pharmaceuticals. Download the . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
Log In
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member
If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

Market Intelligence Resource | March 14, 2011

The Role of the Physician in Medical Marijuana

March 14, 2011 Medical marijuana, legal in 15 states and the District of Columbia, should be federally regulated according to the American Society of Addiction Medicine (ASAM) to strengthen and standardize patient safeguards normally associated with the appropriate clinical use of psychoactive substances. The state-level policies for medical marijuana create a “patchwork system” of safeguards, leaving physicians to regulate use of a substance not approved by the U.S. Food and Drug Administration as medicine. Reliable dosing does not exist, production is not standardized, nor has marijuana been thoroughly tested in the same way as other pharmaceuticals. Download the . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
Log In
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member
If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.